These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: a randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma. Smith II JW; Kurt RA; Baher AG; Denman S; Justice L; Doran T; Gilbert M; Alvord WG; Urba WJ J Immunother; 2003; 26(2):130-8. PubMed ID: 12616104 [TBL] [Abstract][Full Text] [Related]
48. Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer. Lemoine FM; Cherai M; Giverne C; Dimitri D; Rosenzwajg M; Trebeden-Negre H; Chaput N; Barrou B; Thioun N; Gattegnio B; Selles F; Six A; Azar N; Lotz JP; Buzyn A; Sibony M; Delcourt A; Boyer O; Herson S; Klatzmann D; Lacave R Int J Oncol; 2009 Sep; 35(3):569-81. PubMed ID: 19639177 [TBL] [Abstract][Full Text] [Related]
49. Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. Berntsen A; Geertsen PF; Svane IM Eur Urol; 2006 Jul; 50(1):34-43. PubMed ID: 16675096 [TBL] [Abstract][Full Text] [Related]
57. Antitumor vaccination using peptide based vaccines. Eisenbach L; Bar-Haim E; El-Shami K Immunol Lett; 2000 Sep; 74(1):27-34. PubMed ID: 10996624 [TBL] [Abstract][Full Text] [Related]
58. Personalized cancer vaccines: adjuvants are important, too. Gouttefangeas C; Rammensee HG Cancer Immunol Immunother; 2018 Dec; 67(12):1911-1918. PubMed ID: 29644387 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of renal cell carcinoma vaccines targeting carbonic anhydrase IX using heat shock protein 110. Kim HL; Sun X; Subjeck JR; Wang XY Cancer Immunol Immunother; 2007 Jul; 56(7):1097-105. PubMed ID: 17146628 [TBL] [Abstract][Full Text] [Related]
60. Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. Ranieri E; Gigante M; Storkus WJ; Gesualdo L Clin Exp Immunol; 2007 Mar; 147(3):395-400. PubMed ID: 17302887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]